Novartis slashes thousands of jobs in Switzerland, UK

September 25, 2018
Credit: CC0 Public Domain

Pharmaceutical giant Novartis said Tuesday it will cut more than 2,000 jobs in Switzerland by 2022, while some 400 jobs could go in Britain as part of a global restructuring.

The Swiss group said in a statement there would be a net-loss of 1,000 at different manufacturing facilities across the wealthy Alpine nation, in Basel, Schweizerhalle, Stein and Locarno.

But it stressed that this included the recently announced build up of a cell and gene therapy manufacturing unit in Stein that was expected to create up to 450 new jobs.

Another 700 jobs would be meanwhile be cut over the same period due to a shift in business functions from Switzerland to other Novartis sites around the world, according to the company, which currently employs some 12,800 people in Switzerland.

In a separate release, the company said it planned to exit its manufacturing site in Grimsby in Britain by the end of 2020.

"Three hundred and ninety-five Novartis employees at the Grimsby site are directly affected by the decision, and additional contactors employed through third parties may also be impacted," the statement said.

Novartis has already announced adjustments in its manufacturing units in Japan, the US, and other countries as part of a strategy announced in 2015 amid an increased emphasis on specialised and personalised medicines over high-volume products.

"We are continuing our efforts to globally transform Novartis into a more efficient, agile organisation that can sustainably innovate and deliver breakthrough medicines to patients," company chief executive Vas Narasimhan said in a statement.

"We will do everything possible to help our associates who might be impacted manage through this difficult transition," he said, stressing that Novartis remained "deeply committed" to its presence in Switzerland.

The company, he said, will continue to have its global headquarters, largest research and development centre, as well as a growing "advanced footprint" in the country.

The Employe Suisse union meanwhile described Tuesday's announcement as "a bitter pill" and asked Novartis to reconsider moving so many jobs abroad, insisting there was no guarantee this would cut the company's costs.

As for the Grimsby site, Novartis stressed that it was "an effective, well-running operation," and said it was looking at a range of options for it, including divestment, "which could potentially allow the facility to stay open."

"We will treat every employee with the utmost respect, sensitivity and fairness during this difficult time," Haseeb Ahmad, Novartis UK Country President, said in the statement.

Following the news, Novartis saw its share price rise 0.9 percent to 82.54 Swiss francs in early afternoon trading, outperforming the overall Swiss stock exchange's main index.

Explore further: Novartis plans spinoff of Alcon, $5 bn share buy-back

Related Stories

Novartis announces 2,000 job losses, profits up

October 25, 2011

Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.

Novartis to buy back $5 bn in shares

January 25, 2017

Swiss pharmaceutical giant Novartis announced Wednesday a $5.0 billion share buyback even though competition from generics ate away at sales and earnings last year.

Novartis eyes chief executive shake-up in 2018

September 4, 2017

Swiss pharmaceutical giant Novartis said Monday its chief executive for the past seven years, Joseph Jimenez, will step down in 2018, allowing chief medical officer Vasant Narasimhan to take the reins.

Recommended for you

Don't count on your chickens counting

May 16, 2017

Clocks and calendars, sports scores and stock-market tickers - our society is saturated with numbers. One of the first things we teach our children is to count, just as we teach them their ABCs. But is this evidence of a ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.